Small-Cap Healthcare Service Provider Likely to Announce Bonus Shares & Dividend

Thyrocare Technologies Limited inform you that a meeting of the Board of Directors of the company is scheduled to be held on Tuesday, October 14, 2025, to consider, inter alia, the following matters:

1. Consider and approve the unaudited standalone and consolidated financial results of the company for the quarter and half year ended September 30, 2025.
2. Declaration of an interim dividend on the equity shares of the company, for the financial year 2025-26.
3. Proposal for issue of bonus shares, in accordance with the applicable provisions of the Companies Act, 2013 (including the rules framed thereunder), and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, and subject to requisite approval.

Thyrocare Technologies Limited is a well-known Indian chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai, that has made its mark by focusing on providing quality diagnostic tests at affordable prices. Since its founding in 1996, the company has scaled its operations using a unique model that features a fully automated Centralised Processing Laboratory (CPL), which is supported by an extensive network of collection centres and a sophisticated Logistics system. This high-volume, cost-efficient strategy allows Thyrocare to offer a wide range of tests, including its popular 'Aarogyam' wellness packages, making healthcare diagnostics accessible to a broad population across India and internationally.

The company has a market cap of Rs 6,803 crore and has been maintaining a healthy dividend payout of 135 per cent. The stock is up by 93 per cent from its 52-week low of Rs 658 per share.

Disclaimer: The article is for informational purposes only and not investment advice.